Acting commissioner Janet Woodcock will remain at the agency and become principal deputy commissioner when Califf arrives.
Robert Califf, who squeaked through the US Senate to become the first person confirmed twice as Food and Drug Administration commissioner, will return with urgent items already on his agenda, including some pushed to the top to smooth his path to the job.
Califf received only 50 votes in favor of confirmation on 15 February, which was the lowest total a nominee to...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
